Our liver disease research is recognised internationally as highly original clinical and laboratory based. We are currently conducting clinical studies of non-alcoholic fatty liver disease in type 2 diabetes, outcomes of antiviral treatment of hepatitis B and hepatitis C, as well as laboratory investigation into the mechanisms and hepatoprotective therapies for ischemia-reperfusion injury in the liver, pathogenesis of non-alcoholic steatohepatitis (NASH) and liver cancer.
Our gastroenterology research focuses on understanding the mechanisms underlying ulcerative colitis, irritable bowel syndrome and crohn’s disease. We are particularly interested in the interplay between gut microbes and the host immune system.
Research training is a strength of the group with involvement of PhD stuents and post-doctoral fellows, many have won prestigious scholarships/prizes and Young Investigator Awards. Several medical stuent projects are supervised each year.